MedTrace Logo

Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer

NCT05112198 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2026-03-30

No results posted yet for this study

Summary

The purpose of this study is to (1) describe patient and clinician engagement in web-based symptom self-monitoring, (2) identify differences in symptom management between intervention and usual care groups, and (3) identify potential outcomes of real-time symptom tracking and management.

With the assistance of the study coordinator, participants randomized to the intervention will create an account with Noona. Patients will be instructed to log symptoms as often as relevant using their own personal devices. Patients will also be prompted once per week for 24 weeks to log any recent symptoms. These participants will be sent a Symptom Questionnaire (SQ) via the Noona tool that summarizes their symptoms and distress one week prior to each oncology clinic visit. Symptoms designated as clinically severe either during regular symptom logging or via the SQ will trigger a prompt to contact the clinical team for immediate follow-up.

Conditions

  • Quality of Life

Interventions

OTHER

Use of Noona web- based symptom tracking tool

Noona patient reported outcome (PRO) platform tool that summarizes symptoms and distress

Sponsors & Collaborators

  • Varian Medical Systems

    collaborator INDUSTRY

  • Noona Healthcare

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Principal Investigators

  • Kavitha Ramchandran, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2024-08-23
Completion
2024-08-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05112198 on ClinicalTrials.gov